Ion Gel ZCM-25 is a drug candidate for topical application in patients diagnosed with Skin Cancers - Basal Cell Carcinoma and Squamous Cell Carcinoma. The study design will determine the efficacy of clinical improvement or resolution of skin cancer in compliance with the regulatory requirements in Mexico and the applicable international Good Clinical Practice (ICH). Good Clinical Practice (ICH E6 R2).
Considering the high safety profile established in Phase I clinical trial and the preclinical experience of Ion Gel ZCM-25, the following design is proposed.